Licensing Opportunities

The Babraham Institute aims to maximise the impact of its scientific discoveries; where appropriate this is achieved through commercialisation of its intellectual property rights. This primarily involves licensing new discoveries and technologies to pharma and biotech companies, but in some cases commercialisation is achieved through spinning-out new companies such as Crescendo Biologics Ltd.


Enhancing the potency of stem cells
International patent applications filed in USA, Europe, Japan, Australia, Canada, China. (priority date 17th December 2012) Worldwide
Download flyer

International patent applications filed in Europe, USA and Japan (priority date 2nd March 2012) Non-exclusive, worldwide
Download flyer

Capture Hi-C: Deciphering the 3D folding of the genome
Priority patent application filed 5th September 2013. Worldwide
Please contact us for further details.


All reagents are available worldwide non-exclusively through Ximbio